Some older adults with diabetes overtreated for their disease
the ONA take:
According to a new study published in JAMA Internal Medicine, many older adults with diabetes are being overtreated for their disease.
For the study, researchers from Yale University School of Medicine in New Haven, Connecticut, identified nearly 1,300 adults aged 65 years and older with diabetes from the National Health and Nutrition Examination Survey (NHANES) and separated them into three cohorts depending on their state of health: relatively healthy, complex/intermediate health, and very complex/poor health.
Results showed that among all participants, 61.5% had tight glycemic control, which was defined as an A1C less than 7%. In the relatively healthy group, 62.8% had tight glycemic control compared with 63% of those in the complex/intermediate health group and 56.4% of those in the very complex/poor health group.
In addition, about 55% of patients were treated with either sulfonylureas or insulin. Although the American Diabetes Association recommends an A1C level less than 7% among patients with diabetes, older patients are more susceptible to hypoglycemia and may benefit less from such tight glycemic control.
Those with diabetes in complex/intermediate or very complex/poor health are at a higher risk of treatment-related harms and less likely to derive benefit from intensive glycemic control.
Many older adults with diabetes are being overtreated for their disease.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|